Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
The blood collection tubes are used in for blood collection of patient population suffering from different diseases conditions. These blood collection are mostly present in different type in the market including serum separating tubes, edta tubes, plasma separation tubes, rapid serum tubes. These tube have growing requirement across the globe for diagnosis specific disease, or counting the blood cells, among other features. The growing burden of aging population and demand for different end user for blood collection tubes have led the growing demand for the market.
The Asia Pacific blood collection tubes market is majorly driven by rise in the number of surgical procedures and accidents. The region has increasing number of surgical procedure due to growing number of diseases, heart patient, and other diseases which has led the growing demand for blood collection tubes market. Likewise, the regions has increased number of road accidents, road crashes has led the patient inflow in hospital which certainly create demand for blood collection tubes market in the region. Similarly, increase in aging population coupled with widespread of diseases and increasing blood collection and blood donation programs in the region is boosting the market growth.
The exclusive COVID 19 impact analysis report by Axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the Asia Pacific blood collection tubes market. In addition, complete analysis of changes on the North America blood collection tubes market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on global economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The COVID-19 impact on the Asia Pacific blood collection tube was moderately positive due to increasing COVID-19 testing across the globe for identifying the presence of virus has significantly increased the demand for market.
The blood collection tubes market comprises of different market segment like product type, end-user and country
The blood collection tubes is available in market according different product type including serum separating tubes, edta tubes, plasma separation tubes, rapid serum tubes, others. Serum separating tubes is expected to lead in the market as these are used in different medical biochemistry laboratories for performing different testing in blood serum. It is also used for sample storage as a secondary tube. Likewise, edta tubes are experiencing rising demand for the in different end use like diagnostic centers, healthcare centers and research centers among others is driving the market growth.
The blood collection tubes market finds its major end user in diagnostic centers, healthcare centers and research and development centers. Diagnostic centers is expected to gain major market share in the Asia Pacific blood collection tubes market. The increasing number of patient and opinion for blood testing has led the demand for market product in the diagnostic centers. Furthermore, the testing in diagnostic centers available according to different diseases and condition has created new growth opportunity for blood collection tubes market. Similarly, healthcare centers are expected to have growing demand for blood collection tubes market due to constant requirement for blood collection tubes.
Asia Pacific blood collection tubes market is studied for the following countries like China, India, Japan and Rest of APAC among others. China is anticipated to lead in the Asia Pacific blood collection tubes market attributing to growing number of different infectious and demand for diagnostics testing has led the rising requirement for various types of blood collection tubes products. Besides, presence of blood banks, healthcare centers ideally have constant requirement for market products specifically for blood collection, sampling and testing. Likewise, India is expected to hold second position and witness the growth at specific growth rate during the estimated time period. The developing healthcare infrastructure and rising number of number of accident, different diseases, and burden in hospital and diagnostic center has further boosted the growth of Asia Pacific blood collection tubes market.
The key players in blood collection tubes market are Becton, Dickinson and Company, Greiner Bio One International GmbH, QIAGEN, Fl Medical s.r.l., AdvaCare Pharmaceuticals, Narang Medical Limited, Sarstedt AG & Co, Hindustan Syringes & Medical Devices Ltd, Abbott, Medtronic, Improve Medical Instruments Co. Ltd, Cardinal Health, Biosigma, Sunphoria Co., Ltd. and Terumo Corporation.
January 2020: Abacus dx had announced the newest addition to Streck’s trusted blood collection tube portfolio, RNA Complete BCT. The new blood collection tube maintain draw time cell free RNA concentration while limiting the release of extracellular vesicles such as exosomes form the blood cells. RNA Complete BCT maintain these important analytical targets for up to seven days when stored at room temperature allowing convenient sample, collection, transport and storage.
December 2019: SiO2 Materials Science had launched the Synergy Tube, a proprietary blood collection tube as the company’s first genetic diagnostic product on the market. The synergy tube is a BCT specifically designed to optimize nucleic acid recovery and cancer tumor cells (CTC) from the point of blood draw. The synergy tube and proprietary stabilizer dramatically improve the quantity and quality of these component for downstream genetic diagnostics.
February 2018: Becton, Dickinson and Company had announced the commercial availability of CE-IVD market PAXgene Blood ccfDNA tube within the European Economic Area and Switzerland (Western Europe). The plastic blood collection tube which includes a proprietary sample stabilization additive and BD Vacutainer Hemogard technology to protect the healthcare worker safety which was designed to ensure accurte and reproducible results in molecular diagnostic testing application circulating cell free DNA such as cancer and noninvasive prenatal tests. Adding to that the product was developed by PreAnalytiX GmbH, a joint venture between BD and QIAGEN.
September 2016: Becton, Dickinson and Company had secured 510 (k) clearance from the US Food and Drug Administration for its blood collection and separation technology designed to enhance the laboratory efficiency. The BD Vacutainer Barricor plasma blood collection tube will enhance the sample quality, helping the clinicians to rapidly receive test results. Also, the single use, plastic and evacuated tube will effectively obtain plasma from whole blood samples.
The report analyses the Asia Pacific blood collection tubes market based on by product, end-user and country. The blood collection tubes is available in market according different product type including serum separating tubes, edta tubes, plasma separation tubes, rapid serum tubes, others. Serum separating tubes is expected to lead in the market. The blood collection tubes market finds its major end user in diagnostic centers, healthcare centers and research and development centers. Diagnostic centers is expected to gain major market share in the Asia Pacific blood collection tubes market. Asia Pacific blood collection tubes market is studied for the following countries like China, India, Japan and Rest of APAC among others.
Why to buy this report:
